Unlocking dexmedetomidine's therapeutic potential in multiple sclerosis: Dual modulation of PI3K/Akt/BDNF and TLR4/NF-κB pathways in EAE rats. - Salem MA; Rabie MA; El Maraghy NN; El-Said YAM; El Sayed NS; Mansour SM (European journal of pharmacology, 2025)